BriaCell Therapeutics Corp. announced that it has appointed leading immunologist, Alexander Kharazi, M.D., Ph.D., to its Scientific Advisory Board. Dr. Kharazi co-invented Bria-IMT, BriaCell's lead clinical candidate, in collaboration with Dr. Charles L. Wiseman, BriaCell's Founder and Principal Research Advisor. Dr. Khaazi currently serves as Chief Technology Officer at Stemedica Cell Technologies Inc. He is the author of numerous U.S. and international
publications and has been an invited speaker/chairman/panelist on several scientific meetings.